Cargando…
Lung Inflammation Signature in Post-COVID-19 TB Patients
Tuberculosis (TB) remains a leading cause of infectious disease mortality worldwide, despite the COVID-19 pandemic. The mechanisms by which SARS-CoV-2 affects tuberculosis progression have not yet been established. Here, we compared the level of inflammation in the wall of the tuberculoma and in the...
Autores principales: | Shepelkova, Galina S., Evstifeev, Vladimir V., Berezovskiy, Yuriy S., Tarasov, Ruslan V., Bagirov, Mamed A., Yeremeev, Vladimir V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671676/ https://www.ncbi.nlm.nih.gov/pubmed/38003504 http://dx.doi.org/10.3390/ijms242216315 |
Ejemplares similares
-
MicroRNAs as Biomarkers of Active Pulmonary TB Course
por: Shepelkova, Galina S., et al.
Publicado: (2023) -
Interleukin-11 Drives Early Lung Inflammation during Mycobacterium tuberculosis Infection in Genetically Susceptible Mice
por: Kapina, Marina A., et al.
Publicado: (2011) -
High and Low Levels of ABCB1 Expression Are Associated with Two Distinct Gene Signatures in Lung Tissue of Pulmonary TB Patients with High Inflammation Activity
por: Pavlova, Ekaterina N., et al.
Publicado: (2023) -
Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
por: Kogan, Evgeniya, et al.
Publicado: (2022) -
Post-TB lung disease in three African countries
por: Binegdie, A. B., et al.
Publicado: (2022)